Yu-Quan Wei Selected Research

1,2- dioleoyloxy- 3- (trimethylammonium)propane

8/2011	RNA interference-mediated silencing of focal adhesion kinase inhibits growth of human malignant glioma xenograft in nude mice.
1/2011	Therapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancer.
6/2010	RNA interference-mediated silencing of focal adhesion kinase inhibits growth of human colon carcinoma xenograft in nude mice.
5/2010	Enhancement of cisplatin sensitivity in Lewis Lung carcinoma by liposome-mediated delivery of a survivin mutant.
1/2010	Enhanced tumor radiosensitivity by a survivin dominant-negative mutant.
11/2009	Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
10/2008	Vesicular stomatitis virus matrix protein gene enhances the antitumor effects of radiation via induction of apoptosis.
9/2008	Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Quan Wei Research Topics

Disease

131	Neoplasms (Cancer) 01/2022 - 02/2002
21	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2003
17	Carcinoma (Carcinomatosis) 01/2016 - 12/2003
14	Lung Neoplasms (Lung Cancer) 12/2018 - 10/2004
12	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 07/2004
11	Melanoma (Melanoma, Malignant) 05/2015 - 03/2006
10	Colonic Neoplasms (Colon Cancer) 01/2017 - 06/2005
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 11/2009
8	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2009
8	Lewis Lung Carcinoma 06/2014 - 10/2004
7	Colorectal Neoplasms (Colorectal Cancer) 09/2019 - 01/2011
7	Adenocarcinoma of Lung 01/2019 - 10/2004
7	Breast Neoplasms (Breast Cancer) 01/2018 - 09/2008
6	Carcinogenesis 01/2019 - 01/2009
5	Ascites 01/2022 - 06/2006
4	Necrosis 01/2017 - 06/2005
4	Vesicular Stomatitis 03/2016 - 10/2004
3	Infections 01/2019 - 05/2007
3	Fibrosis (Cirrhosis) 01/2018 - 02/2012
3	Inflammation (Inflammations) 01/2018 - 01/2013
3	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2015 - 08/2010
3	Hyperthermia 01/2013 - 06/2008
2	Liver Neoplasms (Liver Cancer) 01/2019 - 11/2008
2	Circulating Neoplastic Cells 01/2019 - 01/2012
2	Tuberculosis (Tuberculoses) 03/2018 - 02/2012
2	Gout 01/2018 - 01/2018
2	Bites and Stings (Sting) 01/2018 - 01/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 02/2012
2	Lymphoma (Lymphomas) 01/2018 - 09/2005
2	Triple Negative Breast Neoplasms 11/2016 - 05/2015
2	Hematologic Neoplasms (Hematological Malignancy) 04/2016 - 04/2016

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 12/2018 - 09/2003
19	VaccinesIBA 01/2017 - 02/2002
15	Liposomes (Liposome)IBA 01/2019 - 09/2008
13	AntigensIBA 12/2021 - 02/2002
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2005
12	Small Interfering RNA (siRNA)IBA 01/2014 - 01/2009
9	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2005
8	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 12/2003
8	Cisplatin (Platino)FDA LinkGeneric 06/2014 - 01/2004
8	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 08/2011 - 09/2008
7	CytokinesIBA 01/2022 - 08/2010
7	Antineoplastic Agents (Antineoplastics)IBA 06/2015 - 08/2006
7	AlginatesIBA 04/2012 - 09/2003
6	Pharmaceutical PreparationsIBA 01/2019 - 07/2010
6	MicroRNAs (MicroRNA)IBA 01/2019 - 07/2010
6	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 05/2014 - 09/2003
6	Gemcitabine FDA Link 12/2012 - 10/2004
6	Biological ProductsIBA 02/2011 - 04/2004
6	Immunoglobulins (Immunoglobulin)IBA 03/2006 - 02/2002
5	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2011
5	SurvivinIBA 09/2011 - 09/2008
5	AutoantibodiesIBA 03/2006 - 02/2002
4	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2016
4	Circular RNAIBA 01/2019 - 01/2018
4	Complementary DNA (cDNA)IBA 12/2018 - 08/2008
4	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018 - 12/2013
4	LigandsIBA 01/2018 - 02/2002
4	Saline SolutionIBA 08/2016 - 04/2005
4	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2015 - 09/2005
4	Angiogenesis InhibitorsIBA 09/2013 - 06/2008
4	Combined VaccinesIBA 04/2013 - 01/2004
4	Therapeutic UsesIBA 11/2012 - 09/2009
4	EnzymesIBA 08/2012 - 04/2005
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2011 - 01/2009
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
3	Phosphotransferases (Kinase)IBA 01/2018 - 07/2008
3	Antiviral Agents (Antivirals)IBA 01/2018 - 03/2015
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 11/2014
3	Cancer VaccinesIBA 01/2017 - 08/2006
3	AntibodiesIBA 01/2017 - 11/2005
3	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2016 - 12/2003
3	Interleukin-12 (IL 12)IBA 11/2015 - 07/2009
3	IntegrinsIBA 05/2015 - 02/2002
3	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 04/2015 - 08/2010
3	EndostatinsIBA 08/2014 - 06/2005
3	pigment epithelium-derived factorIBA 06/2014 - 06/2009
3	Vascular Endothelial Growth Factor DIBA 02/2014 - 06/2009
3	Messenger RNA (mRNA)IBA 08/2012 - 11/2009
3	Focal Adhesion Protein-Tyrosine KinasesIBA 08/2011 - 06/2010
3	Threonine (L-Threonine)FDA Link 05/2010 - 09/2008
3	Alanine (L-Alanine)FDA Link 05/2010 - 09/2008
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2021 - 01/2011
2	nifuroxazide (Akabar)IBA 09/2019 - 01/2017
2	Long Noncoding RNAIBA 12/2018 - 01/2018
2	MethyltransferasesIBA 12/2018 - 01/2018
2	AminesIBA 11/2016 - 05/2015
2	Interleukin-10 (Interleukin 10)IBA 04/2016 - 03/2014
2	MannansIBA 06/2015 - 05/2014
2	Interleukin-4 (Interleukin 4)IBA 04/2015 - 08/2010
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2015 - 07/2006

Therapy/Procedure

64	Therapeutics 01/2022 - 02/2002
24	Immunotherapy 01/2022 - 03/2002
14	Drug Therapy (Chemotherapy) 01/2018 - 04/2004
6	Oral Administration 12/2017 - 01/2011
6	Biological Therapy 01/2016 - 04/2004
4	Radiotherapy 01/2018 - 04/2004
3	Intravenous Injections 05/2010 - 10/2008
2	Transplantation 01/2017 - 06/2008
2	Subcutaneous Injections 04/2015 - 08/2010